NFL BIOSCIENCES (EPA:ALNFL) | WebDisclosure

Basculer en Français

8228	Companies
111072	Keywords
52793	Articles
60962	Press releases

Home
Companies
NFL BIOSCIENCES

REGULATED PRESS RELEASE

published on 01/09/2024 at 17:45, 9 months 29 days ago

NFL BIOSCIENCES: FINANCIAL CALENDAR FOR 2024
NFL Biosciences, a biopharmaceutical company, has announced its financial communication calendar for 2024, including dates for annual results, Annual General Meeting, and half-year results. The company is known for developing botanical drug candidates for the treatment of addictions, such as NFL-101 for nicotine cessation and NFL-301 for reducing alcohol consumption. For more information, visit www.nflbiosciences.com.

NFL Biosciences Biopharmaceutical Company Financial Calendar 2024 Botanical Drug Candidates Addiction Treatment
REGULATED PRESS RELEASE

published on 01/08/2024 at 17:45, 9 months 30 days ago

NFL BIOSCIENCES : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ 2ème SEMESTRE 2023
ARTICLE

published on 12/19/2023 at 08:40, 10 months 20 days ago

NFL Biosciences engage le processus d'approbation de la FDA pour son traitement contre l'alcoolisme
NFL Biosciences vise à renforcer sa présence sur le marché pharmaceutique en proposant une nouvelle solution thérapeutique contre la dépendance à l'alcool

NFL Biosciences FDA Pre-IND Consommation Excessive D'alcool Traitement Des Dépendances
REGULATED PRESS RELEASE

published on 12/19/2023 at 08:00, 10 months 20 days ago

NFL BIOSCIENCES: PRE-IND APPLICATION FILED WITH THE FDA IN THE UNITED STATES FOR NFL-301, INDICATED FOR REDUCING ALCOHOL CONSUMPTION
REGULATED PRESS RELEASE

published on 12/19/2023 at 08:00, 10 months 20 days ago

NFL BIOSCIENCES : DÉPÔT D’UNE DEMANDE DE PRE-IND AUPRÈS DE LA FDA AUX ÉTATS-UNIS POUR NFL- 301 DÉDIÉ À LA RÉDUCTION DE LA CONSOMMATION D’ALCOOL
REGULATED PRESS RELEASE

published on 10/05/2023 at 19:00, 1 year 1 month ago

NFL BIOSCIENCES: 2023 FIRST-HALF BUSINESS AND EARNINGS UPDATE
REGULATED PRESS RELEASE

published on 10/05/2023 at 19:00, 1 year 1 month ago

NFL BIOSCIENCES : ACTIVITÉS & RÉSULTATS DU 1ER SEMESTRE 2023

Accesswire

Published on 11/08/2024 at 14:00, 28 minutes ago

NOA Lithium Closes $912,596 1st Tranche of the $2.7 Million Non-Brokered Private Placement
Published on 11/08/2024 at 14:00, 28 minutes ago

Ballpoint Marketing - Leader in Handwritten Mail - Acquires a Friendly Competitor: Robot Ink Marketing
Published on 11/08/2024 at 13:30, 58 minutes ago

Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
Published on 11/08/2024 at 13:05, 1 hour 23 minutes ago

Aton Announces Corporate and Operations Update
Published on 11/08/2024 at 13:00, 1 hour 28 minutes ago

Honey Badger Announces Change of Transfer Agent

View all ACCESSWIRE

EQS Group

Published on 11/08/2024 at 14:00, 28 minutes ago

Form 8.3 - Zürcher Kantonalbank: Tritax EuroBox PLC
Published on 11/08/2024 at 12:31, 1 hour 57 minutes ago

Original-Research: ORBIS SE (von GSC Research GmbH): Kaufen
Published on 11/08/2024 at 12:30, 1 hour 58 minutes ago

Holding(s) in Company
Published on 11/08/2024 at 12:25, 2 hours 3 minutes ago

freenet Executive Board formulates financial ambition until 2028 - EBITDA and free cash flow to grow significantly
Published on 11/08/2024 at 12:11, 2 hours 17 minutes ago

PNE AG selected by the European Commission for funding a project to produce hydrogen

Les Echos

Published on 11/08/2024 at 12:32, 1 hour 56 minutes ago

Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:32, 1 hour 56 minutes ago

Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 2 hours 13 minutes ago

Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 2 hours 13 minutes ago

Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 08:00, 6 hours 28 minutes ago

DAMARTEX / Droits de vote bruts et réels 31 octobre 2024

View all LES ECHOS COMFI WIRE